Stéphane Boissel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stéphane Boissel
The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $1,433,976 for Stéphane Boissel in fiscal 2020, including a base salary of $318,283. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
Start not stated–2020-07-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, | $318,283 | $1,433,976 |
| 2019 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, | $483,600 | $1,485,282 |
| 2018 | Sangamo Therapeutics, Inc (SGMOQ) | Executive Vice President, Corporate Strategy and former Interim Chief Financial Officer | $120,390 | $2,590,066 |
Recent activity
No call appearances or filed executive changes recorded yet.